Moses Sing Sum Chow
Overview
Explore the profile of Moses Sing Sum Chow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Yeung S, Yang S, Huang Y, Sum Chow M
In Vivo
. 2022 Sep;
36(5):2020-2031.
PMID: 36099129
Background/aim: Prostate cancer is currently the second most common cancer in men and chemotherapy is the main treatment for metastatic castrate-resistant prostate cancers (mCRPC). However, chemoresistance leading to treatment failure...
2.
Wang Z, Ravula R, Shi L, Song Y, Yeung S, Liu M, et al.
Oncotarget
. 2016 Aug;
7(38):61246-61261.
PMID: 27487134
A leading cause of cancer chemotherapy failure is chemoresistance, which often involves multiple mechanisms. Chinese medicines (CM) usually contain multiple components which could potentially target many mechanisms simultaneously and may...
3.
Wang Z, Liu X, Ka Yan Ho R, Kei Lam C, Sum Chow M
Molecules
. 2016 Jul;
21(7).
PMID: 27399658
Although over 100 chemotherapeutic agents are currently available for the treatment of cancer patients, the overall long term clinical benefit is disappointing due to the lack of effectiveness or severe...
4.
Chen S, Wang Z, Huang Y, OBarr S, Wong R, Yeung S, et al.
Evid Based Complement Alternat Med
. 2014 May;
2014:168940.
PMID: 24876866
Ginseng, a well-known herb, is often used in combination with anticancer drugs to enhance chemotherapy. Its wide usage as well as many documentations are often cited to support its clinical...
5.
Che C, Wang Z, Sum Chow M, Kei Lam C
Molecules
. 2013 May;
18(5):5125-41.
PMID: 23644978
Herb-herb combinations have been used in Chinese medicine practice for thousands of years, yet scientific evidence of their therapeutic benefits is lacking. With increasing interest in shifting from the one-drug-one-target...
6.
Chan S, Hu M, Ko S, Tam C, Fok B, Yin O, et al.
Eur J Clin Pharmacol
. 2012 Oct;
69(4):799-806.
PMID: 23090703
Purpose: The pharmacokinetics (PK) of labetalol show wide inter-subject variability, but the genetic causes for this are largely undetermined. This study was performed to examine whether common polymorphisms in UGT1A1,...
7.
Pon D, Wang Z, Bao Le K, Sum Chow M
Ther Deliv
. 2012 Jul;
1(2):335-44.
PMID: 22816136
Traditional Chinese medicine (TCM) has recently yielded a number of chemical compounds with clinically significant anticancer activity. The theory of TCM formulas, however, unlike Western medicine, is based on the...
8.
Yin O, Mak V, Hu M, Fok B, Sum Chow M, Tomlinson B
Eur J Clin Pharmacol
. 2012 Jan;
68(6):943-9.
PMID: 22281720
Purpose: Although CYP3A4/5 enzymes play the predominant role in the metabolism of simvastatin and lovastatin, polymorphisms in CYP2D6 were reported to be associated with the cholesterol-lowering effect and/or tolerability of...
9.
Sum Chow M, Huang Y
Curr Drug Discov Technol
. 2010 Mar;
7(1):1.
PMID: 20230363
No abstract available.
10.
Baum L, Kei Lam C, Cheung S, Kwok T, Lui V, Tsoh J, et al.
J Clin Psychopharmacol
. 2008 Jan;
28(1):110-3.
PMID: 18204357
No abstract available.